QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs) 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2021 作者:  Si, Jinfei;  Gu, Xiaodong;  Wang, Wenxian;  Ying, Shenpeng;  Song, Zhengbo 收藏  |  浏览/下载：59/0  |  提交时间：2022/02/14 Epidermal growth factor receptor (EGFR)  uncommon mutation  compound mutation  double uncommon mutation  lung adenocarcinoma (lung AC)   Immune microenvironment features and efficacy of PD-1/PD-L1 blockade in non-small cell lung cancer patients with EGFR or HER2 exon 20 insertions 期刊论文 THORACIC CANCER, 2020 作者:  Chen, Kaiyan;  Pan, Guoqiang;  Cheng, Guoping;  Zhang, Fanrong;  Xu, Yanjun 收藏  |  浏览/下载：39/0  |  提交时间：2020/12/28 EGFR  HER2  immunotherapy  NSCLC  PD‐  L1   PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文 LUNG CANCER, 2020, 卷号: 142 作者:  Chen, Kaiyan;  Cheng, Guoping;  Zhang, Fanrong;  Zhu, Guanxia;  Xu, Yanjun 收藏  |  浏览/下载：24/0  |  提交时间：2020/11/26 Uncommon EGFR  Non-small cell lung cancer  PD-L1  T cell  Immunotherapy   Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report 期刊论文 ONCOTARGETS AND THERAPY, 2019, 卷号: 12, 页码: 7399-7404 作者:  An, Ning;  Wang, Haoyi;  Zhu, Hui;  Yan, Weiwei;  Jing, Wang 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/11 non-small-cell lung cancer  epidermal growth factor receptor  molecular  targeted therapy  tyrosine kinase inhibitor  afatinib  EGFR rare  mutation   Clinicopathologic characteristics and outcome of patients with different EGFR mutations 期刊论文 2019, 卷号: 15, 期号: 3, 页码: 166-171 作者:  Zhou, Shengyu;  Hu, Xingsheng;  Wang, Yan;  Li, Junling;  Zhou, Liqiang 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 EGFR-tyrosine kinase inhibitors  icotinib  nonsmall cell lung cancer  uncommon EGFR mutations   Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文 2017, 卷号: 29, 期号: 1, 页码: 18-24 作者:  Zhang, Yan;  Wang, Zheng;  Hao, Xuezhi;  Hu, Xingsheng;  Wang, Hongyu 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Non-small cell lung cancer  EGFR  uncommon mutation  target therapy   Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review) 期刊论文 2017, 卷号: 37, 期号: 3, 页码: 1347-1358 作者:  Li, Kaidi;  Yang, Maojun;  Liang, Naixin;  Li, Shanqing 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 epidermal growth factor receptor  non-small cell lung cancer  uncommon mutations  G719X mutation  tyrosine kinase inhibitor  tyrosine kinase inhibitor sensitivity  targeted therapy  methodology   Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29 - 收藏  |  浏览/下载：4/0  |  提交时间：2020/10/26 EGFR MUTATIONS  GEFITINIB TREATMENT  1ST-LINE TREATMENT  OPEN-LABEL  RARE  MULTICENTER  ERLOTINIB  GENE  CHEMOTHERAPY  EFFICACY  Non-small cell lung cancer  EGFR  uncommon mutation  target therapy   miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis 期刊论文 细胞分子免疫学, 2016, 卷号: 13, 期号: 6, 页码: 839-848 作者:  Wang, Lin;  Song, Guanhua;  Zheng, Yabing;  Wang, Dan;  Dong, Hongyan 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/16 EGFR  miR-573  rheumatoid arthritis  TLR2  TXNDC5   miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis 期刊论文 中国免疫学杂志：英文版, 2016, 期号: 06 作者:  Lin Wang[1];  Guanhua Song[2];  Yabing Zheng[3];  Dan Wang[4];  Hongyan Dong[4] 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/17 EGFR  miR-573  风湿性关节炎  TLR2  TXNDC5